1334 / 1851
Endpoints in Drug Development
Early phase
•
Safety
•
Evidence of activity
•
Identifying potential indications
Late phase
•
To confirm clinical benefit
|
|
1334 / 1851
Endpoints in Drug Development
Early phase
•
Safety
•
Evidence of activity
•
Identifying potential indications
Late phase
•
To confirm clinical benefit